Vimarsana
Biggest News Aggregation in the World

Page 3 - Positive Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Positive Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Positive Data Today - Breaking & Trending Today

Q BioMed Inc. Provides Update to Shareholders - Vimarsana News

Q BioMed Inc. Provides Update to Shareholders

/PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO) a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical...

Claritas Completes Acquisition of Exclusive Worldwide - Vimarsana News

Claritas Completes Acquisition of Exclusive Worldwide

Data in Animal Model of PAH Demonstrate Ability of R-107 to Reverse Progression of the Disease...

Claritas Completes Acquisition of Exclusive Worldwide Rights to Develop and Commercialize R-107 for Pulmonary Disease - Vimarsana News

Claritas Completes Acquisition of Exclusive Worldwide Rights to Develop and Commercialize R-107 for Pulmonary Disease

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Euro US Dollar (EUR/USD) Exchange Rate Slides on German Data - Vimarsana News

Euro US Dollar (EUR/USD) Exchange Rate Slides on German Data

The Euro US Dollar (EUR/USD) exchange rate is weakening today as Euro (EUR) sentiment is subdued by falling economic sentiment in Germany.

EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Relief Therapeutics Reports Two Publications of Positive Data on Nexodyn(R) AOS for Hard-to-Heal Ulcers - Vimarsana News

EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Relief Therapeutics Reports Two Publications of Positive Data on Nexodyn(R) AOS for Hard-to-Heal Ulcers

EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Scientific publication Relief Therapeutics Reports Two Publications of Positive Data on Nexodyn(R) AOS for Hard-to-Heal Ulcers 20-Oct-2021